Malignant liver tumours include a wide range of primary and secondary tumours. Although
surgery remains the mainstay of curative treatment, modern therapies integrate a variety of …

Liver metastasis is the commonest form of distant metastasis in colorectal cancer. Selection
criteria for surgery and liver-directed therapies have recently been extended. However …

Colorectal cancer (CRC) is the third most common cancer worldwide, with 1.1 million new
cases per year, and is the second leading cause of cancer death. 1 CRC occurs more …

PURPOSE To develop recommendations for treatment of patients with metastatic colorectal
cancer (mCRC). METHODS ASCO convened an Expert Panel to conduct a systematic …

This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
for Colon Cancer focuses on systemic therapy options for the treatment of metastatic …

PURPOSE Adjuvant chemotherapy after hepatectomy is controversial in liver-only metastatic
colorectal cancer (CRC). We conducted a randomized controlled trial to examine if adjuvant …

Colorectal cancer (CRC) is one of the most common malignancies in Western countries.
Over the last 20 years, and the last decade in particular, the clinical outcome for patients with …

Colorectal cancer is a prevalent disease worldwide, with more than 50% of patients
developing metastases to the liver. Despite advances in improving resectability, most …

In 2012, there were 447000 new cases of colorectal cancer (CRC) in Europe. CRC is the
second most frequent cancer and represents 13.2% and 12.7% of all cancer cases in men …

Background Data suggest selective internal radiotherapy (SIRT) in third-line or subsequent
therapy for metastatic colorectal cancer has clinical benefit in patients with colorectal liver …